Navigation Links
Abbott Announces 10 Percent Increase in Quarterly Dividend
Date:2/19/2010

ABBOTT PARK, Ill., Feb. 19 /PRNewswire-FirstCall/ -- The board of directors of Abbott (NYSE: ABT) today increased the company's quarterly common dividend 10 percent to 44 cents per share.

This marks the 38th consecutive year that Abbott has increased its dividend payout and the 345th consecutive quarterly dividend to be paid by Abbott since 1924.  The cash dividend is payable May 15, 2010, to shareholders of record at the close of business on April 15, 2010.

Abbott was recently named by Money as a leading dividend stock.  Additionally, Abbott is a top performer of the S&P 500 Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for 25 consecutive years.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.  The company employs approximately 83,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at www.abbott.com.

SOURCE Abbott

Back to top

RELATED LINKS
http://www.abbott.com

'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Abbott Completes Acquisition of Solvay Pharmaceuticals
2. Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test
3. Abbott to Provide $1 Million in Funding, Products to Help Address Health Needs in Haiti
4. Feeding America and Abbott Transform Disaster Preparedness Into Hunger Relief
5. Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems
6. Abbott Declares 344th Consecutive Quarterly Dividend
7. Abbott Statement on ARBITER 6 - HALTS Results and Abbotts Niaspan (niacin extended-release)
8. Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
9. Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois
10. Abbott Again Honored for Offering One of the Top 10 Leading Workplaces
11. Abbott Receives FDA Approval for First Fully Automated Blood Screening Test for HIV-1/HIV-2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... 05, 2016 , ... The event is being held on April 7, 2016 ... Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research for the care and ... Parkinson’s disease and is the architect of this informative event to raise awareness and ...
(Date:2/5/2016)... ... February 05, 2016 , ... Looking for a last-minute ... at the tips of your toes. Foot massage, whether administered by a professional masseuse ... and relaxation. The American Board of Multiple Specialties in Podiatry (ABMSP) has ...
(Date:2/5/2016)... ... 2016 , ... The Lymphoma Research Foundation (LRF) – the ... the lymphoma community through a comprehensive series of education programs, outreach initiatives and ... Event at the La Gorce Country Club in Miami Beach on March 15, ...
(Date:2/5/2016)... Grants Pass, OR (PRWEB) , ... February 05, 2016 , ... ... though, with modern technology, such water may be safer than regular municipal or well ... water advocate and radio host Sharon Kleyne, could go a long way toward increasing ...
(Date:2/5/2016)... ... February 05, 2016 , ... Boar’s Head Brand®, one ... time for this weekend’s Big Game. Take the stress out of your party preparation ... your guests happy at every stage of the game. , “The key to hosting ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... 4, 2016  Edwards Lifesciences Corporation (NYSE: EW ... heart disease and critical care monitoring, announced today that ... agreement with Morgan Stanley & Co. LLC to repurchase ... part of the Company,s previously authorized program to repurchase ... --> --> ...
(Date:2/4/2016)... Wegener Polyangiitis - Pipeline Review, H2 ... Polyangiitis - Pipeline Review, H2 2015, provides an ... This report provides comprehensive information on the therapeutic ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ...
(Date:2/4/2016)... Feb. 4, 2016  Omnicell, Inc. (NASDAQ: OMCL ), ... to healthcare systems, today announced results for its fiscal ... --> --> GAAP results: Revenue ... up $5.1 million or 4.1% from the third quarter ... the fourth quarter of 2014. Revenue for the year ...
Breaking Medicine Technology: